Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has brought in an overdue entrance to the radioligand celebration, paying out 100 million eu...

F 2G increases $100M for 2nd try to obtain brand-new antifungal to market

.After F2G's first effort to receive a new training class of antifungal to market was wrecked by the...

Moderna targets $1.1 B in R&ampD costs cuts, falls 5 programs amidst success stress

.Moderna has sworn to cut R&ampD spending through $1.1 billion by 2027. The choice to shrink the spe...

Sanofi's $80M bet on Pivot dystrophy drug ends in stage 3 go belly up

.Simply four months after Sanofi bet $80 million in ahead of time cash on Key Therapeutics' losmapim...

Oncternal stock drains 60% amidst layoffs, test terminations

.Cancer company Oncternal Therapies is folding all its medical trials and also giving up personnel, ...

Roche is supporting out hopes that its own injectable excessive weight possibility could ultimately illustrate 25% weight management in late-stage trial

.Roche is actually holding out hopes that its injectable obesity possibility can at some point displ...

Novo Nordisk hails 'amazing' weight loss lead for dual-acting oral medication in early test

.Novo Nordisk has actually lifted the top on a stage 1 trial of its dental amylin and also GLP-1 rec...

AbbVie takes legal action against BeiGene over blood stream cancer medication proprietary knowledge

.Simply a handful of quick weeks after winning an FDA Fast lane tag for its own investigational BTK ...

Lilly supplies one-two blow with 2nd tranche of good information on every week the hormone insulin candidate

.Shortly after a good information decrease for Eli Lilly's efsitora alfa, the Indianapolis-based com...

BridgeBio cuts gene therapy budget plan as clinical records dissatisfy

.BridgeBio Pharma is actually lowering its own gene therapy budget plan as well as drawing back from...